| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-05 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.59 | 4e-05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.22 | 5e-05 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.13 | 7e-05 |